A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
REDEFINE-HF
Randomized Trial to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Heart Failure Patients With Left Ventricular Ejection Fraction Greater Than or Equal to 40% Hospitalized Due to an Episode of Acute Decompensated Heart Failure (REDEFINE-HF)
1 other identifier
interventional
5,200
22 countries
299
Brief Summary
Finerenone will be compared to placebo to determine efficacy and safety of treatment in patients hospitalized with acute decompensated heart failure (HF) and mildly reduced or preserved left ventricular ejection fraction.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_3 heart-failure
Started Jan 2024
Typical duration for phase_3 heart-failure
299 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 31, 2023
CompletedFirst Posted
Study publicly available on registry
August 23, 2023
CompletedStudy Start
First participant enrolled
January 17, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2027
May 6, 2026
May 1, 2026
3.8 years
July 31, 2023
May 1, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Composite of total HF events and cardiovascular (CV) death.
Total (first and subsequent) HF hospitalizations, urgent visits for worsening HF, and CV deaths with finerenone compared to placebo.
Ongoing, up to ~30 months
Number of serious adverse events.
Occurrence of serious adverse events (excluding efficacy endpoints) with finerenone compared to placebo.
Ongoing, up to ~30 months
Number of adverse events leading to discontinuation of study drug.
Occurrence of adverse events leading to study drug discontinuation with finerenone compared to placebo.
Ongoing, up to ~30 months
Secondary Outcomes (5)
Time to first occurrence of the composite of CV death or HF event.
Ongoing, up to ~30 months
Total HF events.
Ongoing, up to ~30 months
Change from baseline in the Total Symptom Score on the Kansas City Cardiomyopathy Questionnaire (KCCQ-TSS) at Month 6.
6 Months
Time to CV death.
Ongoing, up to ~30 months
Time to death from any cause.
Ongoing, up to ~30 months
Study Arms (2)
Finerenone
EXPERIMENTALPlacebo
PLACEBO COMPARATORInterventions
Eligibility Criteria
You may qualify if:
- Provide written informed consent
- Age ≥18 years or legal age of majority if \>18 years in the participant's country of residence
- Current hospitalization or recently discharged (during or within 30 days of discharge) with the primary diagnosis of heart failure
- Heart failure signs and symptoms at the time of hospital admission
- Imaging evidence of mildly reduced or preserved left ventricular ejection fraction (EF) (40% or higher)
- Elevated N-terminal pro B-type natriuretic peptide (NTproBNP) ≥500 pg/mL or B-type natriuretic peptide (BNP) ≥125 pg/mL for patients without atrial fibrillation (AF); or elevated NTproBNP ≥1500 pg/mL or BNP ≥375 pg/mL for patients with AF
You may not qualify if:
- Current or planned long-term treatment with a mineralocorticoid receptor antagonist (MRA)
- Documented prior history of severe hyperkalemia in the setting of MRA use
- Estimated glomerular filtration rate (eGFR) \<25 mL/min/1.73m² or potassium \>5.0 mmol/L at screening
- Acute myocardial infarction due to plaque rupture, coronary revascularization, valve replacement/repair, or implantation of a cardiac resynchronization therapy device within 30 days
- Hemodynamically significant (severe) uncorrected primary cardiac valvular disease
- Cardiomyopathy due to known acute inflammatory heart, infiltrative diseases, accumulation diseases, muscular dystrophies, cardiomyopathy with reversible causes, known hypertrophic obstructive cardiomyopathy, complex congenital heart disease, or known pericardial constriction
- Probable alternative cause of participant's heart failure symptoms
- Concomitant systemic therapy with potent cytochrome P450 isoenzyme 3A4 (CYP3A4) inhibitors or moderate CYP3A4 inducers, or potent CYP3A4 inducers
- Known hypersensitivity to the IP (active substance or excipients)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Colorado Prevention Centerlead
- St. Luke's Hospital, Kansas City, Missouricollaborator
- Bayercollaborator
Study Sites (299)
Birmingham, AL Investigative Site 10012
Birmingham, Alabama, 35205, United States
Fairhope, AL Investigative Site 10004
Fairhope, Alabama, 36532, United States
Huntsville, AL Investigative Site 10026
Huntsville, Alabama, 35801, United States
Glendale, AZ Investigative Site 10096
Glendale, Arizona, 85304, United States
Scottsdale, AZ Investigative Site 10003
Scottsdale, Arizona, 85258, United States
Chula Vista, CA Investigative Site 10111
Chula Vista, California, 91911, United States
Huntington Beach, CA Investigative Site 10031
Huntington Beach, California, 92648, United States
Los Angeles, CA Investigative Site 10089
Los Angeles, California, 90073, United States
Sacramento, CA Investigative Site 10024
Sacramento, California, 95816, United States
San Francisco, CA Investigative Site 10023
San Francisco, California, 94118, United States
Tarzana, CA Investigative Site 10409
Tarzana, California, 91356, United States
Van Nuys, CA Investigative Site 10109
Van Nuys, California, 91405, United States
West Hills, CA Investigative Site 10013
West Hills, California, 91307, United States
Aurora, CO Investigative Site 10001
Aurora, Colorado, 80045, United States
Denver, CO Investigative Site 10005
Denver, Colorado, 80204, United States
Bradenton, FL Investigative Site 10125
Bradenton, Florida, 34209, United States
Brooksville, FL Investigative Site 10077
Brooksville, Florida, 34613, United States
Fort Lauderdale, FL Investigative Site 10114
Fort Lauderdale, Florida, 33308, United States
Fort Myers, FL Investigative Site 10076
Fort Myers, Florida, 33919, United States
Hialeah, FL Investigative Site 10104
Hialeah, Florida, 33012, United States
Jacksonville, FL Investigative Site 10028
Jacksonville, Florida, 32209, United States
Miami, FL Investigative Site 10105
Miami, Florida, 33135, United States
Miami, FL Investigative Site 10040
Miami, Florida, 33173, United States
Miramar, FL Investigative Site 10113
Miramar, Florida, 33027, United States
Atlanta, GA Investigative Site 10022
Atlanta, Georgia, 30303, United States
Duluth, GA Investigative Site 10083
Duluth, Georgia, 30096, United States
Boise, Idaho Investigative Site 10073
Boise, Idaho, 83712, United States
Chicago, IL Investigative Site 10062
Chicago, Illinois, 60612, United States
Glenview, IL Investigative Site 10021
Glenview, Illinois, 60026, United States
Naperville, IL Investigative Site 10025
Naperville, Illinois, 60540, United States
Peoria, IL Investigative Site 10019
Peoria, Illinois, 61603, United States
Peoria, IL Investigative Site 10010
Peoria, Illinois, 61614, United States
Indianapolis, IN Investigative Site 10074
Indianapolis, Indiana, 46237, United States
Indianapolis, IN Investigative Site 10008
Indianapolis, Indiana, 46260, United States
Merrillville, IN Investigative Site 10064
Merrillville, Indiana, 46410, United States
Kansas City, KS Investigative Site 10060
Kansas City, Kansas, 66103, United States
Lexington, KY Investigative Site 10080
Lexington, Kentucky, 40503, United States
Lexington, KY Investigative Site 10118
Lexington, Kentucky, 40536, United States
Louisville, KY Investigative Site 10006
Louisville, Kentucky, 40202, United States
Louisville, KY Investigative Site 10086
Louisville, Kentucky, 40205, United States
Paducah, KY Investigative Site 10079
Paducah, Kentucky, 42003, United States
Baton Rouge, LA Investigative Site 10030
Baton Rouge, Louisiana, 70808, United States
Hammond, LA Investigative Site 10106
Hammond, Louisiana, 70403, United States
West Monroe, LA Investigative Site 10090
West Monroe, Louisiana, 71291, United States
Baltimore, MD Investigative Site 10101
Baltimore, Maryland, 21287, United States
Bowie, MD Investigative Site 10020
Bowie, Maryland, 20715, United States
Boston, MA Investigative Stie 10087
Boston, Massachusetts, 02114, United States
Minneapolis, MN Investigative Site 10091
Minneapolis, Minnesota, 55407-1139, United States
Minneapolis, MN Investigative Site 10035
Minneapolis, Minnesota, 55417, United States
Tupelo, MS Investigative Site 10100
Tupelo, Mississippi, 38801, United States
Kansas City, MO Investigative Site 10002
Kansas City, Missouri, 64111, United States
Omaha, NE Investigative Site 10018
Omaha, Nebraska, 68105, United States
Camden, NJ Investigative Site 10033
Camden, New Jersey, 08103, United States
Roslyn, NY Investigative Site 10058
Roslyn, New York, 11576, United States
Stony Brook, NY Investigative Site 10017
Stony Brook, New York, 11794-8171, United States
Akron, OH Investigative Site 10081
Akron, Ohio, 44304, United States
Centerville, OH Investigative Site 10119
Centerville, Ohio, 45459, United States
Cincinnati, OH Investigative Site 10088
Cincinnati, Ohio, 45220, United States
Bartlesville, OK Investigative Site 10095
Bartlesville, Oklahoma, 74006, United States
Philadelphia, PA Investigative Site 10068
Philadelphia, Pennsylvania, 19107, United States
Pittsburg, PA Investigative Site 1044
Pittsburgh, Pennsylvania, 15212, United States
Providence, RI Investigative Site 10050
Providence, Rhode Island, 02908, United States
Charleston, SC Investigative Site 10056
Charleston, South Carolina, 29425, United States
Germantown, TN Investigative Site 10063
Germantown, Tennessee, 38138, United States
Memphis, TN Investigative Site 10059
Memphis, Tennessee, 38105, United States
Nashville, TN Investigative Site 10071
Nashville, Tennessee, 37203, United States
Amarillo, TX Investigative Site 10045
Amarillo, Texas, 79106, United States
Austin, TX Investigative Site 10015
Austin, Texas, 78705, United States
Dallas, TX Investigative Site 10042
Dallas, Texas, 75216, United States
Houston, TX Investigative Site 10085
Houston, Texas, 77030, United States
Plano, TX Investigative Site 10014
Plano, Texas, 75093, United States
Burlington, VT Investigative Site 10053
Burlington, Vermont, 05401, United States
Norfolk, VA Investigative Site 10009
Norfolk, Virginia, 23507, United States
Richmond, VA Investigative Site 10069
Richmond, Virginia, 23225, United States
Richmond, VA Investigative Site 10067
Richmond, Virginia, 23249, United States
Salem, VA Investigative Site 10048
Salem, Virginia, 24153, United States
Milwaukee, WI Investigative Site 10061
Milwaukee, Wisconsin, 53226, United States
Buenos Aires Investigative Site 20017
Buenos Aires, Buenos Aires, 1180, Argentina
Buenos Aires Investigative Site 20009
Buenos Aires, Buenos Aires, C1437JC, Argentina
La Plata, Buenos Aires Investigative Site 20023
La Plata, Buenos Aires, 1904, Argentina
Lanús, Buenos Aires Investigative Site 20024
Lanus, Buenos Aires, 1824, Argentina
Corrientes Investigative Site 20001
Corrientes, Corrientes Province, W3400AMZ, Argentina
Córdoba Investigative Site 20025
Córdoba, Córdoba Province, 5000, Argentina
Córdoba Investigative Site 20012
Córdoba, Córdoba Province, 5002, Argentina
Córdoba Investigative Site 20013
Córdoba, Córdoba Province, 5003, Argentina
Córdoba Investigative Site 20016
Córdoba, Córdoba Province, 5003, Argentina
Córdoba, Córdoba Investigative Site 20014
Córdoba, Córdoba Province, 5003, Argentina
Salta Investigative Site 20006
Salta, Salta Province, 4400, Argentina
San Juan, San Juan Investigative Site 20021
San Juan, San Juan Province, 5400, Argentina
San Juan, San Juan Investigative Site 20020
San Juan, San Juan Province, J5402, Argentina
Rafaela, Santa Fe Investigative Site 20026
Rafaela, Santa Fe Province, 2300, Argentina
Rosario, Santa Fe Investigative Site 20003
Rosario, Santa Fe Province, 2000, Argentina
Rosario, Santa Fe Investigative Site 20022
Rosario, Santa Fe Province, 2000, Argentina
Rosario, Santa Fe Investigative Site 20027
Rosario, Santa Fe Province, 5000, Argentina
Rosario, Santa Fe Investigative Site 20019
Rosario, Santa Fe Province, S2000CVD, Argentina
Buenos Aires City Investigative Site 20002
Buenos Aires, 1120, Argentina
Córdoba Investigative Site 20005
Córdoba, 5004, Argentina
Blacktown, NSW Investigative Site 50006
Blacktown, New South Wales, 2148, Australia
Milton, Queensland Investigative Site 50001
Milton, Queensland, 4064, Australia
Elizabeth Vale, South Australia Investigative Site 50008
Elizabeth Vale, South Australia, 5112, Australia
Melbourne, VIC Investigative Site 50005
Melbourne, Victoria, 3121, Australia
Mulgrave, Victoria Investigative Site 50004
Mulgrave, Victoria, 3170, Australia
Rio Branco, Acre Investigative Site 21063
Rio Branco, Acre, 69915-030, Brazil
Arapiraca, Alagoas Investigative Site 21064
Arapiraca, Alagoas, 57315-745, Brazil
Fortaleza, Ceará Investigative Site 21055
Fortaleza, Ceará I, 60864-190, Brazil
Centro Linhares, Espirito Santo Investigative Site 21017
Linhares, Espírito Santo, 29900-010, Brazil
Vila Velha, Espírito Santo Investigative Site 21059
Vila Velha, Espírito Santo, 29118-060, Brazil
Salvador, Bahia Investigative Site 21032
Salvador, Estado de Bahia, 40050-410, Brazil
Brasília, Distrito Federal Investigative Site 21028
Brasília, Federal District, 70390-700, Brazil
Aparecida de Goiânia, Goiás Investigative Site 21053
Aparecida de Goiânia, Goiás, 74936-600, Brazil
Goiânia, Goiás Investigative Site 21003
Goiânia, Goiás, 74453-200, Brazil
Belo Horizonte, Minais Gerais Investigative Site 21013
Belo Horizonte, Minais Gerais, 30441-070, Brazil
Belo Horizonte, Minas Gerais Investigative Site 21020
Belo Horizonte, Minas Gerais, 30180-080, Brazil
Belo Horizonte, Minas Gerais Investigative Site 21051
Belo Horizonte, Minas Gerais, 30220140, Brazil
Poços de Caldas, Minas Gerais Investigative Site 21009
Poços de Caldas, Minas Gerais, 37706-106, Brazil
Curitiba, Parana Investigative Site 21029
Curitiba, Paraná, 80010-030, Brazil
Curitiba, Paraná Investigative Site 21056
Curitiba, Paraná, 80060-900, Brazil
Curitiba, Paraná Investigative Site 21038
Curitiba, Paraná, 80230-130, Brazil
Londrina, Paraná Investigative Site 21047
Londrina, Paraná, 86.038-350, Brazil
Recife, Pernambuco Investigative Site 21061
Recife, Pernambuco, 52010-075, Brazil
Teresina, Piaui Investigative Site 21050
Teresina, Piauí, 64001-450, Brazil
Recife, Recife Investigative Site 21001
Recife, Recife, 50720-110, Brazil
Rio De Janeiro, Rio De Janeiro Investigative Site 21016
Rio de Janeiro, Rio de Janeiro, 20551-030, Brazil
Rio de Janeiro Investigative Site 21034
Rio de Janeiro, Rio de Janeiro, 22280-003, Brazil
Natal, Rio Grande do Norte Investigative Site 21024
Natal, Rio Grande do Norte, 5902050, Brazil
Passo Fundo, Rio Grande do Sul Investigative Site 21042
Passo Fundo, Rio Grande do Sul, 99010 080, Brazil
Porto Alegre, RS Investigative Site 21060
Porto Alegre, Rio Grande do Sul, 90560-032, Brazil
Porto Alegre, Rio Grande do Sul Investigative Site 21025
Porto Alegre, Rio Grande do Sul, 90630-165, Brazil
Porto Alegre, RS Investigative Site 21019
Porto Alegre, Rio Grande do Sul, 90840-440, Brazil
Caxias do Sul, Rio Grande do Sull Investigative Site 21008
Caxias do Sul, Rio Grande Do Sull, 95070560, Brazil
JOINVILLE, Santa Catarina Investigative Site 21007
Joinville, Santa Catarina, 89204250, Brazil
São José, Santa Catarina Investigative Site 21002
São José, Santa Catarina, 88103-450, Brazil
Aracaju, Sergipe Investigative Site 21058
Aracaju, Sergipe, 409055-000, Brazil
Aracaju, Sergipe Investigative Site 21015
Aracaju, Sergipe, 49055-530, Brazil
Atibaia, São Paulo Investigative Site 21057
Atibaia, São Paulo, 12944-060, Brazil
Bragança Paulista, São Paulo Investigative Site 21004
Bragança Paulista, São Paulo, 12916542, Brazil
Itaquera, São Paulo Investigative Site 21005
Itaquera, São Paulo, 08270-120, Brazil
Osasco, São Paulo Investigative Site 21010
Osasco, São Paulo, 06013-070, Brazil
Presidente Prudente, São Paulo Investigative Site 21011
Presidente Prudente, São Paulo, 19050-680, Brazil
Santo André, Sao Paulo Investigative Site 21043
Santo André, São Paulo, 09090790, Brazil
São Carlos, São Paulo Investigative Site 21075
São Carlos, São Paulo, 13566-448, Brazil
São José Dos Campos, Sao Paulo Investigative Site 21012
São José dos Campos, São Paulo, 12230-001, Brazil
São Paulo Investigative Site 21074
São Paulo, São Paulo, 01229-010, Brazil
São Paulo Investigative Site 21054
São Paulo, São Paulo, 01308-070, Brazil
São Paulo, São Paulo Investigative Site 21062
São Paulo, São Paulo, 01317002, Brazil
São Paulo Investigative Site 21037
São Paulo, São Paulo, 01323-001, Brazil
São Paulo, São Paulo Investigative Site 21048
São Paulo, São Paulo, 04004-30, Brazil
São Paulo, São Paulo Investigative Site 21041
São Paulo, São Paulo, 04550-000, Brazil
São Paulo, São Paulo Investigative Site 21035
São Paulo, São Paulo, 04696040, Brazil
São Paulo, São Paulo Investigative Site 21049
São Paulo, São Paulo, 05652900, Brazil
Votuporanga, São Paulo Investigative Site 21031
Votuporanga, São Paulo, 15505-189, Brazil
São Paulo Investigative Site 21066
São Paulo, 05403-000, Brazil
Calgary, AB Investigative Site 11009
Calgary, Alberta, T2N 4Z6, Canada
Edmonton, AB Investigative Site 11018
Edmonton, Alberta, T5H 3V9, Canada
Edmonton, Alberta Investigative Site 11011
Edmonton, Alberta, T6G 2B7, Canada
Kamloops, BC Investigative Site 11021
Kamloops, British Columbia, V2C 2T1, Canada
North Vancouver, BC Investigative Site11020
North Vancouver, British Columbia, V7M2H4, Canada
Surrey, British Columbia Investigative Site 11012
Surrey, British Columbia, V3V 0C6, Canada
Vancouver, BC Investigative Site 11017
Vancouver, British Columbia, V6E 1M7, Canada
Winnipeg, MB Investigative Site 11006
Winnipeg, Manitoba, R2H 2A6, Canada
Cambridge, ON Investigative Site 11003
Cambridge, Ontario, N1R6V6, Canada
Sudbury, ON Investigative Site 11016
Greater Sudbury, Ontario, P3E 5J1, Canada
London, ON Investigative Site 11010
London, Ontario, N6A 5A5, Canada
North York, Ontario Investigative Site 11007
North York, Ontario, M6B3H7, Canada
Toronto, Ontario Investigative Site 11008
Toronto, Ontario, M4N3M5, Canada
Toronto, ON Investigative Site 11019
Toronto, Ontario, M5B 1W8, Canada
Toronto, ON Investigative Site 11001
Toronto, Ontario, M5G 2C4, Canada
Sherbrooke, QC Investigative Site 11005
Sherbrooke, Quebec, J1H 5N4, Canada
Regina, SK Investigative Site 11022
Regina, Saskatchewan, S4P 0W5, Canada
Zagreb Investigative Site 30007
Zagreb, City of Zagreb, 1000, Croatia
Zagreb, Grad Zagreb Investigative Site 30005
Zagreb, Croatia, 10000, Croatia
Rijeka Investigative Site 30009
Rijeka, Primorje-Gorski Kotar County, 51000, Croatia
Krapinske Toplice Investigative Site 30004
Krapinske Toplice, 49217, Croatia
Osijek Investigative Site 30008
Osijek, 31000, Croatia
Varazdin Investigative Site 30002
Varaždin, 42000, Croatia
Zagreb Investigative Site 30001
Zagreb, 10000, Croatia
Zagreb Investigative Site 30003
Zagreb, 10000, Croatia
Zagreb Investigative Site 30006
Zagreb, 10000, Croatia
Chlumec nad Cidlinou, Czech Republic Investigative Site 31005
Chlumec nad Cidlinou, Czech Republic, 30100, Czechia
Plzeň, Czech Republic Investigative Site 31006
Pilsen, Czech Republic, 30100, Czechia
Brno-Zidenice Investigative Site 31011
Brno, Zidenice, 615 00, Czechia
Brno Investigative Site 31002
Brno, 612 00, Czechia
Praha 4 Investigative Site 31003
Prague, 140 21, Czechia
Lübeck Investigative Site 32006
Lübeck, Lübeck, 23538, Germany
Berlin, Berlin Investigative Site 32001
Berlin, State of Berlin, 13353, Germany
Jena Investigative Site 32004
Jena, Thuringia, 07747, Germany
Dresden Investigative Site 32003
Dresden, 01067, Germany
Giessen Investigative Site 32005
Giessen, 35392, Germany
Regensburg Investigative Site 32002
Regensburg, 93053, Germany
Athens, Attica Investigative Site 33001
Athens, Attica, 115 27, Greece
Athens, Attica Investigative Site 33004
Athens, Attica, 115 27, Greece
Athens, Attica Investigative Site 33005
Athens, Attica, 151 23, Greece
Chaidari, Attica Investigative Site 33006
Chaïdári, Attica, 124 62, Greece
Thessaloniki, Central Macedonia Investigative Site 33002
Thessaloniki, Central Macedonia, 546 36, Greece
Athens, Investigative Site 33007
Athens, Greece, 14233, Greece
Larissa, Greece Investigative Site 33003
Larissa, Greece, 41110, Greece
Nyiregyhaza, Hungary Investigative Site 34004
Nyíregyháza, Hungary, 4400, Hungary
Budapest Investigative Site 34001
Budapest, 1122, Hungary
Budapest Investigative Site 34008
Budapest, 1204, Hungary
Kaposvar Investigative Site 34005
Kaposvár, 7400, Hungary
Orosháza Investigative Site 34002
Orosháza, 5900, Hungary
Pecs Investigative Site 34006
Pécs, 7624, Hungary
Szekszárd Investigative Site 34009
Szekszárd, 7100, Hungary
Patna, Bihar Investigative Site 51001
Patna, Bihar, 800014, India
Ahmedabad, Gujarat Investigative Site 51006
Ahmedabad, Gujarat, 380005, India
Kochi, Kerala Investigative Site 51007
Kochi, Kerala, 682018, India
Nagpur, Maharashtra Investigative Site 51009
Nagpur, Maharashtra, 440033, India
New Delhi, Delhi Investigative Site 51004
New Delhi, National Capital Territory of Delhi, 110017, India
New Delhi, Delhi Investigative Site 51011
New Delhi, National Capital Territory of Delhi, 110029, India
New Delhi, Delhi Investigative Site 51005
New Delhi, New Delhi, 110060, India
Mohali, Punjab Investigative Site 51012
Mohali, Punjab, 160062, India
Chennai, Tamil Nadu Investigative site 51008
Chennai, Tamil Nadu, 600 006, India
Bergamo, BG Investigative Site 35001
Bergamo, BG, 24127, Italy
Loc. Germaneto, Catanzaro CZ Investigative Site 35003
Catanzaro, CZ, 88100, Italy
Genova, GE Investigative Site 35005
Genova, GE, 16132, Italy
Varese, Varese Investigative Site 35004
Varese, Varese, 21100, Italy
Alytus, Lithuania Investigative Site 36005
Alytus, Lithuania, LT-62114, Lithuania
Kaunas Investigative Site 36004
Kaunas, LT-50161, Lithuania
Klaipeda Investigative Site 36002
Klaipėda, LT-92231, Lithuania
Johor Bahru Investigative Site 52002
Johor Bahru, Johor, 80100, Malaysia
Alor Setar, Kedah Investigative Site 52006
Alor Star, Kedah, 05460, Malaysia
Kuala Lumpur, Wilayah Persekutuan Investigative Site 52007
Kuala Lumpur, Kuala Lumpur, 50400, Malaysia
Kuantan, Pahang Investigative Site 52004
Kuantan, Pahang, 25100, Malaysia
Kuantan, Pahang Investigative Site 52009
Kuantan, Pahang, 25200, Malaysia
George Town, Penang Investigative Site 52003
George Town, Pulau Pinang, 10050, Malaysia
Kajang, Selangor Investigative Site 52008
Kajang, Selangor, 43000, Malaysia
Kuala, Terengganu Investigative Site 52005
Kuala, Terengganu, 20400, Malaysia
Kuala Lumpur Investigative Site 52001
Kuala Lumpur, 59100, Malaysia
Aguascalientes Investigative Site 23001
Aguascalientes, Aguascalientes, 20230, Mexico
CULIACÁN, Flores Investigative Site 23002
Culiacán, Flores, 80230, Mexico
Guadalajara, Jalisco Investigative Site 23003
Guadalajara, Jalisco, 44280, Mexico
Alcaldía Cuauhtémoc, Ciudad de México Investigative Site 23004
Cuauhtémoc, Mexico City, 06720, Mexico
Ciudad de México Investigative Site 23011
Mexico City, Mexico City, 10700, Mexico
Morelia, Michoacan Investigative Site 23007
Morelia, Michoacán, 58260, Mexico
Monterrey, Nuevo León Investigative Site 23005
Monterrey, Nuevo León, 64460, Mexico
San Nicolás de los Garza, Nuevo León Investigative Site 23008
San Nicolás, Nuevo León, 66465, Mexico
Culiacan, Sinaloa Investigative Site 23006
Culiacán, Sinaloa, 80020, Mexico
Ciudad de México Investigative Site 23009
Mexico City, Tlalpan, 14080, Mexico
Xalapa, Veracruz Investigative Site 23012
Xalapa, Veracruz, 91193, Mexico
Ciudad de México Investigative Site 23010
Mexico City, C.P. 14080, Mexico
Lima, Lima Investigative Site 24011
Lima, Lima Province, 15046, Peru
Lima Investigative Site 24009
Lima, 15036, Peru
Lima Investigative Site 24010
Lima, 15036, Peru
Lima Investigative Site 24003
Lima, 15072, Peru
Lima Investigative Site 24008
Lima, 15076, Peru
Lima Investigative Site 24005
Lima, 15082, Peru
Lima Investigative Site 24004
Lima, 15102, Peru
Lodz Investigative Site 37001
Lodz, 90-549, Poland
Łódź Investigative Site 37003
Lodz, 92213, Poland
Lublin Investigative Site 37006
Lublin, 20-011, Poland
Oświęcim Investigative Site 37002
Oświęcim, 32-600, Poland
Wonju-si, Gangwon-do Investigative Site 53002
Wŏnju, Gangwon-do, 26426, South Korea
Guro-gu, Seoul Investigative Site 53007
Seoul, Guro-gu, 08308, South Korea
Jung-gu, Incheon Investigative Site 53009
Incheon, Incheon, 22332, South Korea
Daejeon, Jung-gu Investigative Site 53004
Daejeon, Jung-gu, 35015, South Korea
Seoul, Seongbuk-gu Investigative Site, 53006
Seoul, Seongbuk-gu, 02841, South Korea
Seodaemun-gu, Seoul Investigative Site 53001
Seoul, Seoul, 03722, South Korea
Badalona, Barcelona Investigative Site 38005
Badalona, Barcelona, 08916, Spain
A Coruña, Galicia Investigative Site 38004
A Coruña, Galicia, 15006, Spain
Santiago De Compostela, Galicia Investigative Site 38008
Santiago de Compostela, Galicia, 15706, Spain
Barcelona, Spain Investigative Site 38010
Barcelona, Spain, 08907, Spain
Manises, Valencia Investigative Site 38009
Manises, Valencia, 46940, Spain
Girona Investigative Site 38017
Girona, 17007, Spain
Madrid Investigative Site 38002
Madrid, 28034, Spain
Madrid Investigative Site 38011
Madrid, 28046, Spain
Madrid Investigative Site 38006
Madrid, 28222, Spain
Murcia Investigative Site 38003
Murcia, 30120, Spain
Valencia Investigative Site 38001
Valencia, 46010, Spain
Valencia Investigative Site 38007
Valencia, 46026, Spain
Kandy, Central Province Investigative Site 54001
Kandy, Central Province, 2000, Sri Lanka
Polonnaruwa, North Central Province Investigative Site 54012
Polonnaruwa, North Central Province, 51000, Sri Lanka
Jaffna, Northern Province Investigative Site 54010
Jaffna, Northern Province, 40000, Sri Lanka
Colombo 02, Western Province Investigative Site 54009
Colombo, Western Province, 00200, Sri Lanka
Colombo 10, Western Province Investigative Site 54004
Colombo, Western Province, 01000, Sri Lanka
Colombo 10, Western Province Investigative Site 54006
Colombo, Western Province, 01000, Sri Lanka
Colombo 10, Western Province
Colombo, Western Province, 01000, Sri Lanka
Boralesgamuwa, Western Province Investigative Site 54011
Colombo, Western Province, 10290, Sri Lanka
Dehiwala, Western Province Investigative Site 54007
Dehiwala, Western Province, 10350, Sri Lanka
Negombo, Western Province Investigative Site 54002
Negombo, Western Province, 11500, Sri Lanka
Nugegoda, Western Province Investigative Site 54003
Nugegoda, Western Province, 10250, Sri Lanka
Ragama, Western Province Investigative Site 54008
Ragama, Western Province, 11010, Sri Lanka
Kaohsiung City, Taiwan, Investigative Site 55002
Kaohsiung City, Taiwan, 807, Taiwan
Taipei, Taiwan Investigative Site 55008
Taipei, Taiwan, 106, Taiwan
Taipei City, Taiwan Investigative Site 55009
Taipei, Taiwan, 112401, Taiwan
Brighton, East Sussex Investigative Site 39021
Brighton, East Sussex, BN2 1ES, United Kingdom
Southampton, Hampshire Investigative Site 39006
Southampton, Hampshire, SO16 6YD, United Kingdom
Ashford, Kent Investigative Site 39020
Ashford, Kent, TN02 0LZ, United Kingdom
Liverpool, Liverpool Investigative Site 39024
Liverpool, Liverpool, L9 7AL, United Kingdom
Chester, North West England Investigative Site 39022
Chester, North West England, CH2 1UL, United Kingdom
Ashington, Northumberland Investigative Site 39017
Ashington, Northumberland, NE63 9JJ, United Kingdom
Dudley, West Midlands Investigative Site 39018
Dudley, West Midlands, DY1 2HQ, United Kingdom
Cardiff, Investigative Site 39015
Cardiff, CF14 4XW, United Kingdom
Glasgow Investigative Site 39001
Glasgow, G4 0SF, United Kingdom
London, Investigative Site 39016
London, SE5 9RS, United Kingdom
London, Investigative Site 39002
London, SW17 0QT, United Kingdom
Manchester Investigative Site 39003
Manchester, M13 9WL, United Kingdom
Plymouth, Investigative Site 39014
Plymouth, PL6 8DH, United Kingdom
Portadown, Investigative Site 39005
Portadown, BT63 5QQ, United Kingdom
Swindon Investigative Site 39004
Swindon, SN3 6BB, United Kingdom
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 31, 2023
First Posted
August 23, 2023
Study Start
January 17, 2024
Primary Completion (Estimated)
November 1, 2027
Study Completion (Estimated)
December 1, 2027
Last Updated
May 6, 2026
Record last verified: 2026-05
Data Sharing
- IPD Sharing
- Will not share
No current plan to share individual patient data with other researchers.